(Q39769727)

14 September 2017

title

Use of Thymosin in the Treatment of Primary Immunodeficiency Diseases and Cancer (English)

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31900-9

10 December 2022

author name string

A. L. Goldstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A131889

10 December 2022

G. H. Cohen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A131889

10 December 2022

J. L. Rossio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A131889

10 December 2022

G. B. Thurman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A131889

10 December 2022

C. N. Brown

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A131889

10 December 2022

J. T. Ulrich

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A131889

10 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=131889

10 December 2022

publication date

1 May 1976

1 reference

full work available at URL

14 September 2017

https://api.elsevier.com/content/article/PII:S0025712516319009?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31900-9

https://api.elsevier.com/content/article/PII:S0025712516319009?httpAccept=text/plain

10 December 2022

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31900-9

Medical Clinics of North America

10 December 2022

published in

1 reference

14 September 2017

volume

60

1 reference

14 September 2017

issue

3

1 reference

14 September 2017

page(s)

591-606

1 reference

Reduction in the Incidence of Wasting Disease in Neonatally Thymectomized CBA/W Mice by the Injection of Thymosin

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Appearance of T-cell markers in bone marrow rosette-forming cells after incubation with thymosin, a thymic hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Abnormalities of quantitative dinitrochlorobenzene sensitization in cancer patients: correlation with tumor stage and histology

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Lymphocyte reactivity in cancer patients: Correlation with tumor histology and clinical stage

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Thymosin-induced differentiation of murine thymocytes in allogeneic mixed lymphocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Cellular Immune Competence of Breast Cancer Patients Receiving Radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Thymosin Corrects the Abnormal DNA Synthetic Response of NZB Mouse Thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Thymus-dependent lymphocyte levels during radiation therapy for bronchogenic and esophageal carcinoma: correlations with clinical course in responders and nonresponders

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Thymus-dependent lymphocyte levels in bronchogenic carcinoma: Correlations with histology, clinical stage, and clinical course after surgical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Impaired immunologic reactivity and recurrence following cancer surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Purification and Biological Activity of Thymosin, a Hormone of the Thymus Gland

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin)

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Immunodeficiency in chronic uremia. Preliminary evidence for thymosin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Purification and properties of bovine thymosin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Immunotherapy of the Dunning leukaemia with thymic extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Influence of Thymosin on Immunological Competence of Lymphoid Cells from Thymectomized Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Thymus-derived lymphocytes in patients with solid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Thymosin-induced increase in E-rosette-forming capacity of lymphocytes in patients with malignant neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Differentiation of T cells induced by preparations from thymus and by nonthymic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Thymosin-induced reduction of "null cells" in peripheral-blood lymphocytes of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Effect of therapeutic irradiation on lymphocyte transformation in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Thymic hormones and the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Letter: Effect of thymosin on B-lymphocyte function

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Thymosin activity in patients with cellular immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Thymus-Derived Rosette-Forming Cells in Various Human Disease States: Cancer, Lymphoma, Bacterial and Viral Infections, and Other Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Thymosin: effects on normal human blood T-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Acceleration by thymosin of the development of resistance to murine sarcoma virus-induced tumor in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931900-9

7 January 2021

Induction of PHA response in mouse bone marrow cells by thymic extracts as studied by changes in the structuredness of cytoplasmic matrix

8

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31900-9

Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer

10 December 2022

55

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31900-9

The role of thymosin in lymphocyte maturation

10 December 2022

58

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31900-9

10 December 2022

Identifiers

0 references

1 reference